Cell differentiation versus cell death: Extracellular glucose is a key determinant of cell fate following oxidative stress exposure

Cell Death and Disease

Volumn 5, Issue 2, 2014, Pages

  Poulsen, R C ^a   Knowles, H J ^a   Carr, A J ^a   Hulley, P A ^a  

^a MASSEY UNIVERSITY   (New Zealand)

Author keywords

forkhead; hyperglycaemia; hypoxia inducible factor; sirtuin 3; tenocyte; type 1 collagen

Indexed keywords

BIM PROTEIN; COLLAGEN TYPE 1; GLUCOSE; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 28 5P; MITOGEN ACTIVATED PROTEIN KINASE 14; PROTEIN; PROTEIN P53; RNA; SCLERAXIS; SIRTUIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL TYPE; CELLULAR STRESS RESPONSE; COLLAGEN SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXTRACELLULAR SPACE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TENDON; TENOCYTE; TRANSCRIPTION REGULATION; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; ENZYME ACTIVATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MEMBRANE PROTEINS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 14; OXIDANTS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; SIRTUIN 3; SOX9 TRANSCRIPTION FACTOR; TENDONS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84896785165     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.52     Document Type: Article

References (54)

1. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001; 11: 173-186.
2. Li D, Xie G, Wang E. Reactive oxygen species: The 2-edged sword of osteoarthritis. Am J Med Sci 2012; 344: 486-490.
3. Ames B, Shigenaga M, Hagen T. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci 1993; 90: 7915-7922.
4. Gambino V, De Michele G, Venezia O, Migliaccio P, Dall'Olio V, Bernard L et al. Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging. Aging Cell 2013; 12: 435-445.
5. Kops G, Dansen TB, Polderman PE, Saarloos I, Wirtz KWA, Coffer PJ et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002; 419: 316-321.
6. Tothova Z, Kollipara R, Huntly B, Lee B, Castrillon D, Cullen D et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007; 128: 325-339.
7. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999; 96: 857-868.
8. Lowe S, Schmitt E, Smith S, Osborne B, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849.
9. Cohen H, Miller CM, Bitterman KJ, Wall N, Hekking B, Kessler B et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305: 390-392.
10. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang Z, Yamauchi T et al. Glucose or diabetes activates p38 mitogen-Activated protein kinase via different pathways. J Clin Invest 1999; 103: 185-195.
11. Ogawar Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K et al. Akt enhances Mdm2-mediated ubiquitination and degradaton of p53. J Biol Chem 2002; 277: 21843-21850.
12. Agani F, Jiang B. Oxygen-independent regulation of Hif-1: Novel involvement of PI3K/AKT/ mTOR pathway in cancer. Curr Cancer Drug Targets 2013; 13: 245-251.
13. Hubbi M, Hu H, Kshitiz, Gilkes D, Semenza G. Sirtuin-7 inhibits the activity of hypoxiainducible factors. J Biol Chem 2013; 288: 20768-20775.
14. Chiacchiera F, Matrone A, Ferrari E, Ingravallo G, Lo Sasso G, Murzilli S et al. p38a blockade inhibits colorectal cancer growth in vivo by inducing a switch from Hif1a-To FoxO-dependent transcription. Cell Death Differ 2009; 16: 1203-1214.
15. Pagé E, Chan D, Giaccia A, Levine M, Richard D. Hypoxia-inducible factor 1a stabilization in nonhypoxic conditions: Role of oxidation and intracellular ascorbate depletion. Mol Biol Cell 2008; 19: 86-94.
16. Basu R, Hibchak S, Hayashida T, Runyan C, Schumacker P, Schnaper H. Interdependence of Hif-1 alpha and TGF-beta/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am J Physiol Renal Physiol 2011; 300: F898-F905.
17. Gilkes D, Bajpai S, Chaturvedi P, Wirtz D, Semenza G. Hypoxia-inducible factor 1 (Hif-1) promotes extracellular matrix remodeing under hypoxic conditions by inducing P4HA1, P4HA2 and PLOD2 expression in fibroblasts. J Biol Chem 2013; 288: 10819-10829.
18. Umegaki H. Neurodegeneration in diabetes mellitus. Adv Exp Med Biol 2012; 724: 258-265.
19. Peterson Kim R, Edelma S, Kim D. Musculoskeletal complications of diabetes mellitus. Clin Diabetes 2001; 19: 132-135.
20. Sukenik S, Weitzman S, Buskila D, Eyal A, Gross J, Horowitz J. Limited joint mobility and other rheumatological manifestations in diabetic patients. Diabetes Metab 1987; 13: 187-192.
21. Rechardt M, Shiri R, Karppinen J, Jula A, Heliovaara M, Viikari-Juntura E. Lifestyle and metabolic factors in relation to shoulder pain and rotator cuff tendinitis: A population-based study. BMC Musculoskeletal Dis 2010; 11: 11.
22. Carson D, Ribeiro J. Apoptosis and disease. Lancet 1993; 341: 1251-1254.
23. Yang Y, Zhao Y, Liao W, Yang J, Wu L, Zheng Z et al. Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment. Neoplasia 2009; 11: 313-324.
24. Polyak K, Xia Y, Zweier J, Kinzler K, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-305.
25. Chuang PY, Yu Q, Fang W, Uribarri J, He JC. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney Int 2007; 72: 965-976.
26. Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, Liu MF et al. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J 2009; 28: 2719-2732.
27. Fontana L, Fiori M, Albini S, Cifaldi L, Giovinazzi S, Forloni M et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and bim. Plos One 2008; 3: E2236.
28. Vaziri H, Dessain SK, Eagon EN, Imai SI, Frye RA, Pandita TK et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-159.
29. Li SD, Banck M, Mujtaba S, Zhou MM, Sugrue MM, Walsh MJ. p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. Plos One 2010; 5: E10486.
30. Colla S, Storti P, Donofrio G, Todoerti K, Bolzoni M, Lazzaretti M et al. Low bone marrow oxygen tension and hypoxia-inducible factor-1a overexpression characterize patients with multile myeloma: Role on the transcriptional and proangiogenic profiles of CD138+ cells. Leukemia 2010; 24: 1967-1970.
31. Calnan D, Brunet A. The FoxO code. Oncogene 2008; 27: 2276-2288.
32. Siugimoto Y, Takimoto A, Akiyama H, Kist R, Scherer G, Nakamura T et al. Scx(+)/Sox9(+) progenitors contribute to the establishment of the junction between cartilage and tendon/ligament. Development 2013; 140: 2280-2288.
33. Amarilllo R, Viukov S, Sharir A, WEshkar-Oren I, Johnson R, Zelzer E. Hif1alpha regulation of sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 2007; 134: 3917-3928.
34. McNaughton C, Self W, Slovis C. Diabetes in the emergency department: Acute care of diabetes patients. Clin Diabetes 2011; 29: 51-59.
35. Renault V, Thekkat P, Hoang K, White J, Brady C, Kenzelmann Broz D et al. The pro-longevity gene FOXO3 is a direct target of the p53 tumor suppressor. Oncogene 2011; 1-15.
36. You H, Yamamoto K, Mak TW. Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc Nat Acad Sci 2006; 103: 9051-9056.
37. Bouchard C, Lee S, Paulus-Hock V, Loddenkemper C, Eilers M, Schmitt C. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct actiavtion of Arf. Genes Develop 2007; 21: 2775-2787.
38. Yang J, Xia W, Hu M. Inonizing radiation activates expression of FOXO3a, Fas ligand and bim and induces apoptosis. Int J Oncol 2006; 29: 643-648.
39. Eijkelenboom A, Burgering M. FOXOs: Signalling integrators for homeostasis maintenance. Nature Rev Mol Cell Biol 2013; 14: 83-97.
40. Leiser SF, Miller RA. Nrf2 signaling, a mechanism for cellular stress resistance in long-lived mice. Mol Cell Biol 2010; 30: 871-884.
41. Yang M, Yao Y, WEades G, Zhang Y, Zhou Q. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res Treat 2011; 129: 983-991.
42. Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H et al. Mitogen-Activated protein kinases Erk and p38 phosphorylate and regulate FOXO1. Cell Signal 2007; 19: 519-527.
43. Ho K, McGuire V, Koo C, Muir K, de Olano N, Maifoshie E et al. Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localisation in response to doxorubicin. J Biol Chem 2012; 287: 1545-1555.
44. Clavel S, Siffroi-Fernandez S, Coldefy A, Boulukos K, Pisani D, Dé rijard B. Regulation of intracellular localisation of FOXO3a by stress-Activated ptotein kinase signaling pathways in skeletal muscle cells. Mol Cell Biol 2010; 30: 470-480.
45. Kwon S, Song J, Lee Y. Signal pathway of hypoxia-inducible factor-1a phosphorylation and its interaction with von Hippel-Lindau tumour suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells. Clin Cancer Res 2005; 11: 7607-7613.
46. Nakagami H, Morishita R, Yamamoto K, Yoshimura S, Taniyama Y, Aoki M et al. Phosphorylation of p38 mitogen-Activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 2001; 50: 1472-1481.
47. Gutierrez-Uzquiza Á, Arechederra M, Bragado P, Aguirre-Ghiso J, Porras A. p38a mediates cell survival in response to oxidative stress via induction of antioxidant genes. J Biol Chem 2012; 287: 2632-2642.
48. Nebreda A, Porras A. p38 MAP kinases: Beyond the stress response. Trends Biochem Sci 2000; 25: 257-260.
49. Lé jard V, Brideau G, Blais F, Salingcarnboriboon R, Wagner G, Roehrl MHA et al. Scleraxis and NFATc regulate the expression of the pro-Alpha 1(I) collagen gene in tendon fibroblasts. J Biol Chem 2007; 282: 17665-17675.
50. Espira L, Lamoureux L, Jones S, Gerard R, Dixon I, Czubryt M. The basic helix-loop-helix transcription factor scleraxis regulates fibroblast colagen synthesis. J Mol Cell Cardiol 2009; 47: 188-195.
51. Poulsen R, Carr A, Hulley P. Protection against glucocorticoid-induced damage in human tenocytes by modulation of ERK, Akt and forkhead signalling. Endocrinology 2011; 152: 503-514.
52. Yao L, Bestwick CS, Bestwick LA, Maffulli N, Aspden RM. Phenotypic drift in human tenocyte culture. Tissue Eng 2006; 12: 1843-1849.
53. Morten K, Badder L, Knowles HJ. Differential regulation of Hif-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J Pathol 2013; 229: 755-764.
54. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.